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A B ST R AC T 
 
 
Breast cancer patients are vulnerable to elevated stress related to receiving 
the diagnosis, unfamiliar and invasive treatment, and coping with the side-
effects of treatment, which may find various forms of expression.  Another 
common feature of this patient population is body image dysphoria. Both the 
disease and treatment lead to impairments in physical appearance and 
general bodily functioning. This study aimed to explore the differential 
manifestations of stress and the nature of body image dysphoria within a 
sample of female breast cancer patients (n=80), compared to female patients 
with other sites of disease (n=80) in order to examine differences in the 
experiences of distress in these groups. Patients completed 4 questionnaires 
relating to psychological distress and body image dysphoria. The results 
showed the breast patients reported significantly higher levels of body image 
dysphoria and reflected differential indicators of stress, namely more 
psychological and behavioral expression, as compared to the other group. 
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Breast cancer is the most frequent cancer in women and 
is the second most common cancer in general. More than 2 
million new diagnoses worldwide were reported in 2018 
[1]. While rates of breast cancer have been higher among 
women in developed regions of the world, rates are rising 
nearly everywhere [2]. Cancer survival has improved since 
the mid‐1970s largely due to improvements in detection 
practices and the increased use of adjuvant systemic 
therapies, inter alia newer cytotoxic drugs, adjuvant 
hormonal therapy and biologics, in addition to regional 
radiotherapy [3,4]. Due to these advances, a growing 
number of cancer patients will become long-term 
survivors, living with the physiological and psychological 
effects of their disease and treatment [5].  
A cancer diagnosis is an important source of 
psychological distress and is followed by an extended 
interval of treatment which in itself is also experienced as 
stressful [6]. Studies indicate that women with breast 
cancer are among the most distressed of the subgroups of 
cancer diagnoses and report distress related to fear of 
disease progression and recurrence. This distress may 
manifest as depressed mood, stress, and elevated anxiety 
relating to prognosis, disability, and death [7]. 
Previous studies suggest that psychological disorders 
negatively affect treatment, cancer progression, and 
outcomes, and thus exert a significant effect on morbidity 
and mortality [8,9]. As such, the importance of the patient’s 
psychological well-being cannot be overstated. A key goal 
in breast cancer therapy is to improve the support of the 
growing numbers of women diagnosed with the disease to 
facilitate adjustment into survivorship in the long-term [5]. 
Breast cancer research has historically concentrated on 
both the physical and mental health sequelae of cancer and 
its treatment, but commonly health care providers tend to 
focus chiefly on patients’ physical symptoms, and place 
less emphasis on mental health [5]. Stress and the well 
documented insults to body image faced by patients are 
common features of the psychological distress which these 
patients experience, which negatively impacts the patient’s 
ability to adjust after cancer and into survivorship [10].  
This research follows on and expands on a previous 
study [11], and goes on to explore the aetiology of 
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psychological distress in these patients in more detail. 
Further facets of body image disturbances and the 
complexity of body image responses to breast disease are 
examined and useful therapeutic interventions are 
discussed. 
Cancer-specific stress disorders in breast patients 
In the context of this study, stress is defined generally 
as a multidimensional construct referring to an individual’s 
response to external conditions and more subjectively, as 
the response to the appraisal of these demands, which is 
mediated by one’s coping skills [12].  
The human stress response may be conceptualized as 
both physiologically- and psychologically- based. In terms 
of physiology, both acute and chronic stress following a 
life event such as the diagnosis of cancer have implications 
for the disruption of various neurotransmitters and 
neurohormones. Neurotransmitters impact both the 
physical and psychological functioning of the individual 
experiencing stress. In psychological terms, problems with 
the cognitive processing of a stressor may precipitate a 
stress response. Both perception and cognitive appraisal 
are critical in this functioning, and information from the 
pre-frontal cortex and frontal lobes (the decision making 
and higher cognitive function centres of the brain) mediates 
emotional, psychological, and behavioural outcomes. The 
physiological and psychological pathways interrelate 
closely, resulting in a stress cascade that involves both the 
endocrine and autonomic nervous systems, thereby 
incorporating a hormonal element. Interactions between 
neurotransmitters, stress hormones, and negative effect of 
these on the immune system resulting from 
chronic/enduring stress, can alter the balance between 
neurotransmitters [13].  
With respect to cancer patients, both of these stress 
pathways are pertinent. Somatic disease in itself may cause 
physical stress reactions where pain or other symptoms 
may give rise to severe distress. Furthermore, oncological 
treatments frequently generate physiological stress through 
excessive demand on the body by way of painful and often 
invasive onco-therapeutic interventions. Psychological 
stress appears to stem from the individual’s understanding 
that the diagnosis implies a life-threatening disease and 
having to live with its consequences. The symptoms of 
cancer-specific stress include, inter alia, intrusive thoughts, 
marked negative emotions towards cancer diagnoses, and 
treatments together with avoidant cognitions and 
behaviours.  These symptoms of stress are all associated 
with deficits in quality of life (QOL) and correlated with 
poorer clinical outcomes, while in animal models of cancer 
there is evidence that stress may decrease the effectiveness 
of treatment or increase resistance to chemotherapeutic 
agents [6,14]. 
Stress is considered a major precipitating psychological 
issue for cancer patients from diagnosis through treatment 
and prognosis, and even long after treatment has been 
completed. It is a significant comorbidity as it is associated 
with the growth and progression of disease and is closely 
related to further psychological comorbidities such as 
anxiety and depression [15]. Indeed, research indicates that 
it is the chronicity of negative affect such as anxiety, 
depressed mood, and/or hopelessness that appears to 
correlate more strongly with outcomes than is true of 
stressful events, suggesting that it is the prolonged arousal 
of negative affective pathways that furnishes the strongest 
association with disease progression through its effect on, 
inter alia, tumour growth, angiogenesis and metastasis 
[14,16]. Studies suggest that these stress-induced 
neurobiological changes lead to significant impairment of 
the immune system and prolonged anxious behavior 
changes [14]. Mood disturbances, including depression 
and anxiety, correlate highly with stress and, as such, mood 
disturbance has been commonly used as an indicator of 
stress [6]. 
Some research indicates that while initial stress 
following a diagnosis of cancer tends to decrease over time, 
a notable proportion of patients continue to experience 
elevated levels of stress, sometimes for years after 
successful completion of oncological treatment. In some 
cases, patients may even go on to develop posttraumatic 
stress disorder (PTSD) resulting from the cancer diagnosis, 
indicating varying responses to the same stressor of cancer 
diagnosis [6]. 
Body image disorders in breast cancer patients 
Body image is widely acknowledged to be a critical 
psychosocial issue for breast cancer patients and studies 
show that the better the patient’s body image, the better is 
the capacity to cope with cancer [17]. The construct of 
body image is multidimensional and encompasses feelings, 
perceptions, thoughts, and behaviors associated with the 
whole body and how it functions [8]. It has been described 
as a subjective picture the individual forms in her mind 
regarding her own body, based on her observations of 
herself and by judging what others think, based on their 
reactions, with associated features such as emotional 
expression, imitation, identification, ideals of beauty, and 
social factors [17,19].  
According to the Cash [20] cognitive-behavioural 
model of body image, inherent in the concept of body 
image is the notion of satisfaction or dissatisfaction with 
one's body that is modified by two factors, appearance 
investment and self‐evaluation. Appearance investment 
refers to the individual's own view of the significance of 
appearance and physical attributes, where self‐evaluation 
refers to the contextual cultural ideals of beauty in physical 
appearance, the degree to which the individual is satisfied 
with her appearance, and whether there is dissonance 
between the subjective perception of her physical 
characteristics and the ideal characteristics. Since research 
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suggests that the breast forms part of a woman's identity 
and femininity and that women are socialized to perceive 
that their personal value is bound up with their outward 
appearance [21], it is clear that change or loss of a breast 
will have a notable impact on the patient’s sense of her 
body and its attractiveness.  
Studies suggest that body image is closely correlated 
with both psychological and physical symptoms including 
identity, self‐esteem, perceptions of attractiveness, and 
social interactions. Thus, body image disorders are 
associated with poorer self‐esteem, increased social 
anxiety, greater self‐consciousness, and depressive 
symptoms and, furthermore, they are significantly related 
to anxiety, fatigue, and fear of recurrence [17]. As such, 
there exists a significant correlation between psychological 
distress and poor body image [19].  
Breast cancer therapy commonly results in adverse 
effects with visible and nonvisible physiological impacts 
(10). Patients receiving treatment for breast cancer are 
exposed to significant changes in their appearance, such as 
the loss or disfigurement of the breast, surgical scarring, 
radiotherapy related skin changes and weight gain resulting 
from systemic treatments. These changes are closely bound 
to appearance and body image [19]. Upwards of 50% of 
breast cancer survivors experience body image-related 
concerns regarding both their body appearance and 
function. Adjusting to these physiological changes is 
challenging because treatment is demanding, both 
physically and emotionally, and is associated with 
increased psychopathology including anxiety and 
depression. Research suggests that one in every three 
breast cancer patients experiences chronic body-related 
distress, such as fear of or shame regarding their altered 
bodies, which disrupts attempts to resume normal life after 
cancer [10].  
In terms of age, younger women have been found to be 
particularly at risk for psychological distress during and 
after treatment since these women often have more 
aggressive breast cancers and tend to attach greater 
importance to their breasts in terms of their femininity and 
sexuality [17]. Stage of treatment is an additional factor in 
the development of body image disorders with some 
studies suggesting that oncological treatment significantly 
affects body image and the patient’s quality of life 
immediately post-surgery and adjuvant treatment whereas 
other research suggests that body image concerns only 
emerge at a later time [22,23]. 
Materials and Methods 
Participants 
Convenience sampling was used to select participants 
for this study. 80 female breast cancer patients and 80 
female patients receiving treatment for other types of 
cancer, (ovary, cervix, lung, and colon) were canvassed to 
participate. All were patients at three oncology outpatient 
treatment facilities within the Durban, Kwa-Zulu Natal, 
South Africa area, receiving adjuvant chemotherapy or a 
combination of chemo-and radiotherapy. Some had 
previously undergone surgery. In order to meet the 
inclusion criteria, participants had to be between the ages 
of 30 and 70 years with no history of disease or other 
comorbid conditions. The identified patients were 
approached by the researcher and invited to take part in the 
study of their psychological experiences during treatment. 
The participants all provided written and oral consent 
before taking part. 
Materials 
Participants meeting the inclusion criteria were given a 
demographic questionnaire and a series of 4 questionnaires 
to complete. 
• Brief demographic questionnaire: a brief demographic 
questionnaire detailing the participant’s age, marital status, 
and medical history. 
• The Beck Depression Inventory (BDI) [24]: This is a 
widely-used, 21-item multiple-choice inventory measuring 
attitudes and severity of depressive symptomatology. 
Pertinent to the present study are items relating to 
irritability, pessimism, feelings of guilt or being punished, 
self-dissatisfaction, and social withdrawal, in addition to 
physiological symptoms such as tiredness, weight loss, and 
loss of libido. This inventory evaluates depression in 
normal and psychiatric populations. Several items indicate 
the presence of hopelessness and suicidal ideation. Items 
are scored on a 4-point continuum, with the total score 
range being 0–63. High scores point to more severe level 
of depression. 
• The Rosenberg Self-Esteem Scale [25]: This widely-
used scale measures global self-esteem using a 10-item 
Likert-type scale. It comprises a scale of 0–30, with a score 
of less than 15 indicative of low self-esteem. Of the 10 
items, five are positively worded statements and five are 
negatively worded. This scale measures global self-worth 
by means of measuring both positive and negative 
perceptions of the self. It is considered reliable and valid 
for the assessment of self-esteem 
• The Stress Symptom Checklist (SSCL) [26]: This is an 
87-item checklist relating to symptoms of unhealthy stress. 
The intensity or severity of stress is measured as reported 
by the patient’s reactions across 3 dimensions: physical (18 
items), psychological (27 items), and behavioural (42 
items). Each dimension is separately scored with a score of 
three or more indicative of elevated stress. High scores 
signify high levels of stress. The maximum score is 87. The 
checklist allows for further interpretation, with scores of 8 
and below indicative of low stress, mild stress ranging from 
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9 to 15, moderate stress from 16 to 30, and the severe stress 
from 31 to 45. Profound stress is reflected in scores of 46 
and above. Moreover, the SSCL offers an indication as to 
whether the respondent reflects stress reactions which are 
mainly physical or psychological and/or behavioural in 
nature. This scale is a useful clinical measure of stress. 
• Body Image Scale (BIS) [18]: The BIS is a 10-item, 
patient-reported outcome scale designed to briefly but 
comprehensively rate 3 dimensions of body image, for use 
exclusively with cancer patients: the affective (pertaining 
to feelings such as self-consciousness), behavioural (for 
example difficulties with looking at oneself naked) and 
cognitive (level of satisfaction with appearance). There is 
a 4-point response scale, the final score being the sum of 
all 10 items, with a range of 0-30. Low scores signify fewer 
symptoms and lower levels of body image distress while 
higher scores are associated with more symptoms and 
greater body image dysphoria. 
Results 
Data were analyzed using non-parametric tests as the 
frequency of the scores was not normally distributed. The 
Mann Whitney (two-sample Wilcoxon rank-sum test) was 
used to compare differences between the breast and other 
groups on the measures administered. 
The BDI results suggest that no notable differences 
exist between the breast and other group in terms of levels 
of depression (p=0.3) and the measures of the majority of 
patients fell within the minimal/mild range. Similarly, the 
Rosenberg Self-esteem Scale showed no significant 
differences between the breast and other group (p=0.2) 
indicating that both groups reported similar measures of 
self-esteem, with the majority of all the patients scores 
falling within the low average range.  
In terms of stress, according to the SSCL results, no 
notable differences emerged between the groups on 
measures of physiological reactions, however other 
differences were apparent (Table 1).  
 
Table 1. Results of SSCL: Psychological and behavioural responses. 
Stress response  Breast   Other Total p-value 
Psychological n % n %   
<5 26 32.5 42 52.5 68 0.055 
5-9 13 16.3 7 8.8 20  
10-14 9 11.3 7 8.8 16  
15-19 7 8.8 5 6.3 12  
20-24 7 8.8 2 2.5 9  
25-30 7 8.8 8 10.0 15  
31-34 4 5.0 3 3.8 7  
35-39 5 6.3 1 1.3 6  
40-46 2 2.5 5 6.3 7  
Total 80 100 80 100   
Behavioural       
<5 12 15.0 30 37.5 42 0.002 
5-9 16 20.0 15 18.8 31  
10-14 15 8.8 9 11.3 24  
15-19 5 6.3 7 8.8 12  
20-24 6 7.5 4 5.0 10  
25-30 4 5.0 2 2.5 6  
31-34 4 5.0 2 2.5 6  
35-39 2 2.5 1 1.3 3  
40-45 5 6.3 5 6.3 10  
46-49 6 7.5 3 3.8 9  
50-64 5 6.3 2 2.5 7  
Total 80 100 80 100   
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Although no notable differences emerged between the 
two groups along physiological responses to stress, 
significant differences in psychological (p=0.055) and 
behavioural (p=0.002) manifestations of stress were found. 
In terms of the psychological responses, the most notable 
differences emerged on items related to feelings of tension 
or being “keyed up” (p=0.007), low self-esteem (p=0.04), 
and self-dislike (p=0.021), with the breast group reflecting 
higher scores on these measures. Moreover, behavioural 
responses yielded significant differences, in particular on 
items relating to irritability (p=0.001), restlessness 
(p=0.003), experiencing emotional outbursts frequently 
(p=0.002), and difficulties with concentration (p=0.001), 
with the breast cancer group again experiencing these 
reactions more frequently. In sum, this suggests that 
patients with breast cancer experience more severe 
psychological and behavioural stress symptoms than do 
patients with other sites of disease.  
The results of the BIS also showed significant 
differences between the breast and other group on several 
items, with the breast group reflecting higher levels of body 
image dissatisfaction on all items (Table 2). 
 
Table 2. Results of the Body Image Scale 
BIS item response breast  other   p-value 
   n % n % total  
1. Have you been feeling self-conscious 
about your appearance? 
Not at all 
A little 























2 Have you felt less physically 
attractive as a result of your disease or 
treatment? 
Not at all 
A little 























3. Have you been dissatisfied with your 
appearance when dressed? 
Not at all 
A little 























4. Have you been feeling less feminine 
as a result of your disease or treatment? 
Not at all 
A little 























5. Did you find it difficult to look at 
yourself naked? 
Not at all 
A little 























6. Have you been feeling less sexually 
attractive as a result of your disease or 
treatment? 
Not at all 
A little 























7. Did you avoid people because of the 
way you felt about your appearance? 
Not at all 
A little 























8. Have you been feeling the treatment 
has left your body less whole? 
Not at all 
A little 























9. Have you felt dissatisfied with your 
body? 
Not at all 
A little 























10. Have you been dissatisfied with the 
appearance of your scar? 
Not at all 
A little 
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The most significant differences between the breast and 
other groups emerge with respect to feelings of sexual 
attractiveness (p=0.001) and physical attractiveness 
(p=<0.001) as a result of the disease and treatment, with 
the breast cancer group reporting significantly less 
satisfaction with physical and sexual attractiveness. 52 
respondents from the other group reported no problems 
with feeling physically unattractive whilst only 22 patients 
from the breast group had no difficulties with perceptions 
of physical unattractiveness. With regard to feelings of 
being sexually unattractive, 10% of the other group noted 
extreme feelings of unattractiveness while 16.3% of the 
breast group experienced marked feelings of sexual 
unattractiveness attributed to the disease and treatment. 
Further differences were found in terms of dissatisfaction 
with one’s body (p=0.02), social avoidance resulting from 
body dissatisfaction (p=0.01) and feeling less feminine 
(p=0.01) as a result of disease and treatment. On all these 
measures, the breast group scored consistently higher 
results.  
These findings correspond with the results of other 
studies which have suggested that breast cancer and its 
treatment engender higher levels of body image dysphoria 
in patients than does disease in other sites. 
Discussions 
The principal goal of this study was the examination of 
the psychological distress experienced by female breast 
cancer patients and the identification of the differences in 
psychological experience which these patients undergo, 
with particular reference to expression of stress and issues 
of body image. Since the literature widely shows that breast 
patients experience elevated levels of stress and more 
severe body image dysphoria when compared to patients 
with other forms of disease, this study set out to determine 
the accuracy of these findings. 
In terms of stress, the results of the SSCL indicate that 
breast cancer patients expressed their levels of stress post-
diagnosis more through psychological and behavioural 
responses than did the other group. Reactions such as 
tension, low opinion of the self, and self-dislike emerged 
as significant differences between the responses of the two 
groups with the breast patients reporting experiencing 
these more intensely. Similarly, in terms of behavioural 
manifestations of stress, the breast group reported more 
severe symptoms of irritability, restlessness, emotional 
outbursts, and impaired ability to concentrate, symptoms 
which are well described in the literature as being 
associated with stress in breast patients [27]. Further, 
features such as fearfulness, apathy, social isolation, and 
difficulty with remembering and decision-making were 
more marked in the breast group, confirming the results of 
previous studies [28].  
These results underscore that patients in the breast 
group experienced stress more intensely and severely than 
did patients in the general group, and through differential 
means, suggesting that the experience of distress for these 
patients differs in nature and severity to that of other 
patients. 
The findings here also confirm that breast patients 
experience greater body image distress as reported on all 
the items of the BIS, with significantly higher measures of 
dysphoria in terms of physical and sexual attractiveness, 
loss of feelings of femininity, and elevated levels of self-
consciousness, which yielded the most notable differences 
between the two groups. Interestingly, while 22.5% of the 
breast respondents reported intense feelings of self-
consciousness about their appearance, approximately half 
of that number viz. 10.0% reported difficulties with 
looking at themselves naked. Similarly, while 16.3% of the 
breast group reported marked feelings of sexual 
unattractiveness resulting from the disease and treatment, 
only 8.8% reported notable negative effects on feelings of 
femininity. Some studies have suggested that while self-
consciousness appears to be linked to a woman's identity, 
her naked appearance is very closely associated with her 
perception of her body. Moreover, the concept of 
femininity is overarching and thus broader than sexual 
attractiveness [29].  
Research suggests that women are generally more 
dissatisfied with the appearance of their bodies than are 
men [30], and this tendency is exacerbated by the diagnosis 
and treatment associated with oncology. Previous studies 
have identified impairments in sexual attractiveness and 
sexual intimacy as a critical issue for women in terms of 
body image during their treatment, particularly those who 
have undergone mastectomy and that self-consciousness 
and dissatisfaction with their bodies have emerged as 
impacting significantly on patients’ body image 
perceptions [23]. A recent study has demonstrated further 
body image issues, such as discomfort about self-image, 
loss of confidence in body functioning, and avoiding 
intimacy or exposing the physical self, as critical in these 
patients. The same study found that grief expressions 
relating to loss of function or of the perceived prior 
attractive self were prevalent. In addition, the patients 
feared being regarded as vain for articulating their body 
image concerns, feeling they should feel gratitude for their 
survival instead [31]. 
Therapeutic interventions 
Optimal treatment of breast cancer-specific distress is 
supportive and problem‐focused [32]. Education, control 
of physical symptoms, and maintenance of effective and 
inter-disciplinary communication constitute critical 
factors.   
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Studies suggest that various interventions may improve 
patients’ coping with distress, improve their affect, and 
reduce the negative effects of disease or treatment, thereby 
improving their quality of life. Five types of intervention 
were found to be effective, especially when used jointly: 
education regarding the disease, behavioral training, for 
example relaxation or yoga, cognitive-behavioral therapy 
(CBT) including training in coping skills, stress 
management skills, and support in professionally led or 
group contexts [33].  
Supportive‐expressive therapy is focused on current 
life issues, challenges to optimal coping, and the 
facilitation of expression of emotions. CBT is aimed at 
helping patients to identify negative or irrational thoughts 
they may have regarding themselves and their disease, to 
examine how these thoughts lead to dysfunctional 
behaviors and then guides the patient as to how to 
assimilate more reasonable thoughts and more adaptive 
behaviors [34]. CBT has been shown to positively affect 
many psychological outcomes, particularly depression, 
anxiety, and mood disorders [35]. CBT may include 
coaching in relaxation techniques to alleviate stress, 
psychoeducation, cognitive restructuring, and graduated 
exposure to feared or unwanted thoughts and both CBT and 
supportive expressive therapy have been shown to be 
effective in reducing symptoms of psychological distress 
in cancer patients [36,37]. A significant improvement in 
QOL measures was observed in women receiving CBT on 
an individual level [35]. A recent study found that an 
exposure-based cognitive-behavioral body image 
intervention was successful in bringing about positive 
changes in body image disturbance, with noted 
improvements in related symptoms such as depression and 
self-esteem [38]. 
Highlights 
✓ Breast cancer patients experience psychological 
distress differently as compared to patients with other 
sites of disease. 
✓ Specific body image disturbances and elevated stress 
are prominent sequelae of breast cancer. 
✓ The prevalence and severity of these comorbid 
symptoms warrant closer observation of patients to 
facilitate identification those at risk of distress. 
Conclusions 
This study was aimed at the examination of the 
differential nature of psychological distress as experienced 
by breast cancer patients in particular. It is broadly 
acknowledged that breast cancer is a disease which 
connotes unique comorbidities owing to the significance of 
the breast as a sexual organ. These findings confirm 
previous data in that, with respect to specifically body 
image issues and stress, the patients were found to 
experience elevated levels of distress as compared to 
patients with cancers in other sites. The breast patient is 
more vulnerable to feelings of impaired femininity, a 
diminished perception of her sexual attractiveness, and a 
tendency towards social avoidance resulting from 
increased feelings of self-consciousness. Similarly, with 
respect to the experience of stress, the breast patient 
undergoes higher levels of psychological and behavioural 
symptomatology, including tension, irritability and 
restlessness. 
These results indicate that both body image and stress 
remain significant issues for the rising numbers of patients 
undergoing adjuvant treatment for breast cancer. The goal 
of oncology is not to merely extend survival intervals but 
also to optimize the patient’s quality of life. While the 
literature suggests that mental health issues are often 
under-diagnosed and undertreated in oncology patients, it 
is now clearly critical that healthcare professionals, 
particularly those working in the field of oncology, become 
more aware of the singular psychological issues facing 
breast cancer patients in order to maximize their ability to 
deliver quality care. 
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